(From the July 2014 Research Now)
Jonathan L. Finlay, MB, ChB, FRCP, joined Nationwide Children’s Hospital as director of Neuro-Oncology on July 1. Dr. Finlay will also be a tenured professor of pediatrics at The Ohio State University College of Medicine.
As director of Neuro-Oncology, Dr. Finlay will lead an innovative approach to brain tumor treatment, for which he has served as principal investigator in a series of “Head Start” clinical trial protocols, the first three phases of which grew to include more than 40 institutions.
The Head Start protocol is a randomized clinical trial that will be hosted at and coordinated by Nationwide children’s, with other treatment centers participating around the world. Head Start is also one of the first research endeavors to operate within the Nationwide Children’s McConnell NEXT Consortium, a collaborative research model for investigator-initiated studies that contribute to the early development of promising new therapies for childhood cancer and blood diseases.
“We are elated to welcome Dr. Finlay to Nationwide Children’s Hospital,” says Timothy Cripe, MD, PhD, division chief of Hematology/Oncology/BMT at Nationwide Children’s and also a professor of pediatrics at The Ohio State University College of Medicine. “Nationwide Children’s is poised to be an international destination for the care of pediatric, adolescent and young adult patients with malignant brain and spinal cord tumors.”
Prior to coming to Nationwide Children’s, Dr. Finlay was the director of the Neural Tumors Program at Children’s Hospital Los Angeles and served as Professor of Pediatrics, Neurology, and Neurological Surgery at the Keck School of Medicine in the University of Southern California. Dr. Finlay is an internationally recognized expert in pediatric brain tumors and has co-authored more than 180 peer-reviewed publications in leading medical journals and more than 80 review articles and book chapters.
“With Dr. Finlay’s leadership and the close collaboration of neuro-oncology with neurosurgery, neuropathology, neuroradiology and other important programs, Nationwide Children’s Hospital is now positioned to offer the most advanced care for pediatric central nervous system tumors with a true emphasis on quality of life, reduced side effects and better outcomes,” says Jeffrey Leonard, MD, chief of neurosurgery at Nationwide Children’s and faculty member at The Ohio State University College of Medicine.